Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients

被引:2
|
作者
Ergunay, Koray [1 ]
Yurdakul, Pinar [1 ]
Sener, Burcin [1 ]
Ozcelik, Ugur [2 ,3 ]
Karabulut, Erdem [4 ]
Kiper, Nural [2 ,3 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Microbiol & Clin Microbiol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Pediat, Div Chest Dis, TR-06100 Ankara, Turkey
[3] Ihsan Dogramaci Childrens Hosp, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey
来源
CENTRAL EUROPEAN JOURNAL OF MEDICINE | 2008年 / 3卷 / 02期
关键词
DNA extraction; PCR; Burkholderia; Burkholderia cepacia complex; cystic fibrosis;
D O I
10.2478/s11536-007-0069-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Direct detection of Burkholderia cepacia complex (BCC) and its genomovars from sputum by molecular tests emerges as a method for rapid identification. In this study, four DNA extraction methods were evaluated forth e identification for BCC from sputum of CF patients. Sputa from 28 CF patients were aliquoted and spiked with BCC reference strain. Boiling, phenol-chloroform, CTAB methods and a commercial spin column kit was used for DNA extraction. Total DNA yields were determined by spectrophotometry and single-round recA PCR was used for detection of BCC. No significant difference was observed in DNA yields from different extraction methods. Lower limit of detection for recA PCR was determined as 10(6) cfu/ml. Amplification was observed in 7/16 (43.7%) of sputa for boiling, 8/16 (50%) of sputa for GTAB and 13/16 (81.2%) of sputa for phenol-chloroform method and spin column kit in the assay sensitivity range determined in the study. Phenol-chloroform and commercial spin column kit were found to be better suited for DNA purification from sputum of CF patients for BCC identification. Diagnostic impact of single-round recA PCR directly from sputum was limited to chronically-infected patients.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [21] Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand
    Pope, Christopher E.
    Short, Patricia
    Carter, Philip E.
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (06) : 442 - 446
  • [22] Polyphasic characterisation of Burkholderia cepacia complex species isolated from children with cystic fibrosis
    Vicenzi, Fernando Jose
    Pillonetto, Marcelo
    Peres Homem de Mello de Souza, Helena Aguilar
    Palmeiro, Jussara Kasuko
    Riedi, Carlos Antonio
    Rosario-Filho, Nelson Augusto
    Dalla-Costa, Libera Maria
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2016, 111 (01): : 37 - 42
  • [23] Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy
    Santana, Juan Carlos Gutierrez
    Jimenez, Victor Rafael Coria
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [24] Mucoid and Nonmucoid Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Infections
    Zlosnik, James E. A.
    Costa, Paulo S.
    Brant, Rollin
    Mori, Paul Y. B.
    Hird, Trevor J.
    Fraenkel, Monica C.
    Wilcox, Pearce G.
    Davidson, A. George F.
    Speert, David P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (01) : 67 - 72
  • [25] Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid
    Correa-Ruiz, Ana
    Giron, Rosa
    Buendia, Buenaventura
    Jose Medina-Pascual, M.
    Valenzuela, Claudia
    Lopez-Brea, Manuel
    Antonio Saez-Nieto, Juan
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (10): : 649 - 654
  • [26] Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
    Bryan A. Garcia
    Jacque L. Carden
    Dana L. Goodwin
    Tim A. Smith
    Amit Gaggar
    Kevin Leon
    Veena B. Antony
    Steven M. Rowe
    George M. Solomon
    BMC Pulmonary Medicine, 18
  • [27] Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
    Garcia, Bryan A.
    Carden, Jacque L.
    Goodwin, Dana L.
    Smith, Tim A.
    Gaggar, Amit
    Leon, Kevin
    Antony, Veena B.
    Rowe, Steven M.
    Solomon, George M.
    BMC PULMONARY MEDICINE, 2018, 18
  • [28] Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis
    Marrs, Emma C. L.
    Perry, Audrey
    Perry, John D.
    MICROORGANISMS, 2021, 9 (12)
  • [29] Susceptibility of Burkholderia cepacia Complex to Ceftazidime/Avibactam and Standard Drugs of Treatment for Cystic Fibrosis Patients
    Schaumburg, Frieder
    Idelevich, Evgeny A.
    Mellmann, Alexander
    Kahl, Barbara C.
    MICROBIAL DRUG RESISTANCE, 2022, 28 (05) : 545 - 550
  • [30] Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center
    Priscila Dentini
    Fernando Augusto Lima Marson
    Luciana Cardoso Bonadia
    Carmen Sílvia Bertuzzo
    Antônio Fernando Ribeiro
    Carlos Emílio Levy
    José Dirceu Ribeiro
    Medical Microbiology and Immunology, 2017, 206 : 447 - 461